Flushing: Causes, investigation and clinical consequences

Journal of the European Academy of Dermatology and Venereology

Volumn 8, Issue 2, 1997, Pages 91-100

  Greaves, M W ^a   Burova, E P ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

carcinoid syndrome; drugs; flushing; food; mastocytosis; physiological response; rosacea

Indexed keywords

CROMOGLYCATE DISODIUM; HISTAMINE H2 RECEPTOR ANTAGONIST; METHYSERGIDE; OCTREOTIDE; SEROTONIN ANTAGONIST;

CARCINOID SYNDROME; FLUSHING; FOOD ALLERGY; HUMAN; MASTOCYTOSIS; PRIORITY JOURNAL; REVIEW; ROSACEA;

EID: 0030903618     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(97)00615-6     Document Type: Article

References (60)

1. Fox RH, Goldsmith P, Kidd DJ. Cutaneous vasomotor control in human head, neck and upper chest. J Physiol 1962; 161: 298-312.
2. Gonzalez G, Onofrio BM, Kerr FWL. Vasodilator system for the face. J Neurosurg 1975;42:696-703.
3. Wilkin JK. Skin changes in the flushing disorders and the carcinoid syndrome. In: Fitzpatrick TB, Eisen AZ, Wolfe K et al., eds. Dermatology in General Mediane. New York: McGraw-Hill, 1993:2133-2135.
4. Wilkin JK. Quantitative assessment of alcohol-provoked flushing. Arch Dermatol 1986;119:211-214.
5. Wilkin JK. Effect of subdepressor clonidine on flushing reactions in rosacea. Arch Dermatol 1983;119:211-214.
6. Wilkin JK. Oral thermal-induced flushing in erythemato-telangiectatic rosacea. J Invest Dermatol 1981;76:15-18.
7. Mulley G, Mitchell GRA. Menopausal flushing: does oestrogen therapy make sense? Lancet 1976;1:1397-1398.
8. Wilkin JK. Flushing reactions. Consequences and mechanisms. Ann Int Med 1981;95:468-476.
9. Wolff PU. Ethnic differences in alcohol sensitivity. Science 1972;175:449-450.
10. Harada S, Agarwal DP, Goedde HW. Aldehyde dehydrogenase deficiency as cause of facial flushing reaction to alcohol in Japanese. Lancet 1981;2:982.
11. Wiles PG, Pyke DA. The chlorpropamide alcohol flush. Clin Sci 1984;67:375-381.
12. m aldehydedrogenase deficiency. Lancet 1987;1: 629.
13. Barnett AH, Spiliopoulos AJ, Pyke DA. Blockade of chlorpropamide alcohol flushing by indomethacin suggests an association between prostaglandins and diabetic vascular complications. Lancet 1980;2:164-166.
14. Kwok RMA. Chinese Restaurant syndrome. N Engl J Med 1968;278:796.
15. Ghadimi H, Kumar S, Abaci F. Studies on monosodium glutamate ingestion. Biochem Med 1971;5:447-456.
16. Wilkin JK. Does monosodium glutamate cause flushing (or merely 'glutamania'). J Am Acad Dermatol 1986;15:225-230.
17. Rosenblum I, Bradley JD, Coulston F. Single-and double-blind studies with oral monosodium glutamate in man. Toxicol Appl Pharmacol 1971;18:367-373.
18. Kim R. Flushing syndrome due to Mahimahi (scombroid fish) poisoning. Arch Dermatol 1979;115:963-965.
19. Morrow JD, Margolies GR. Rowland J, Roberts LJ. Evidence that histamine is the causative toxin of scombroid fish poisoning. N Engl J Med 1991;324:716-720.
20. Cunliffe WJ, Black MM, Hall R et al. A calcitonine secreting thyroid carcinoma. Lancet 1968;2:63-66.
21. Murray JS, Paton RR, Pope CE. Pancreatic tumour associated with flushing and diarrhea. N Engl J Med 1961;264:436-439.
22. Gulledge AD, Kavanaugh GJ, Priestley JT. Cutaneous flushing as a primary manifestation of functioning insulinoma: report of a case. Mayo Clin Proc 1967;42:547-550.
23. Myers BM, Miralles GD, Taylor CA et al. POEMS Syndrome with idiopathic flushing mimicking carcinoid syndrome. Am J Med 1991;90:646-648.
24. Wereide K, Neset G. Skin manifestations in carcinoid syndrome. Acta Derm Venerol (Stockholm) 1961;41:264-276.
25. Smith AG, Greaves MW. Blood prostaglandin activity associated with the noradrenaline-provoked flush in the carcinoid syndrome. Br J Dermatol 1974;90:547-551.
26. Vinik A, Moattari AR. Use of somatostatin analog in management of carcinoid syndrome. Dig Dis Sci 1989;37:14S-27S.
27. Fries JF, Lindgren JA, Bull JM. Scleroderma-like lesions and the carcinoid syndrome. Arch Int Med 1973;131:550-553.
28. Lee SS, Biro L, Price E. Pyoderma gangrenosum with carcinoid tumour. Cutis 1976;18:791-794.
29. Beaton H, Homan W, Dineen P. Gastrointestinal carcinoids and the malignant carcinoid syndrome. Surg Gynecol Obstet 1981;152:268-272.
30. Williams ED, Sandler M. The classification of carcinoid tumours. Lancet 1963;1:238-239.
31. Archer CB, Wells RS, MacDonald DM. Metastatic cutaneous carcinoid. J Am Acad Dermatol 1985;13:363-366.
32. Oates JA, Sjoedsma A. A unique syndrome associated with secretion of 5-hydroxytryptophan by metastatic gastric carcinoids. Am J Med 1962;32:333-342.
33. Granerus G, Ahlman H. Histamine metabolism in patients with foregut carcinoid tumours. Agents Actions 1993; 38:C165-C168.
34. Cruetzfeldt W, Stockmann F. Carcinoids and carcinoid syndrome. Am J Med 1987;82(Suppl. 5B):4-16.
35. Engelman K, Lovenberg W, Sjoerdsman A. Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome. N Engl J Med 1967;277: 1103-1108.
36. Baron DN, Dent CE, Harris H et al. Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal amino-aciduria, and other bizarre biochemical features. Lancet 1956;11:421-428.
37. Adamson AR, Grahame-Smith DG, Peart WS et al. Pharmacological blockade of carcinoid flushing provoked by catecholamines and alcohol. Lancet 1969;ii:293-297.
38. Lamberts SW, Bakker WH, Reube JC, Krenning EP. Somatostatin receptor imaging in localisation of endocrine tumours. N Engl J Med 1990;323:1246-1249.
39. Norheim I, Oberg K, Theodorsson-Norheime E. Malignant carcinoid tumours. An analysis of 103 patients with regard to tumour localization, hormone production, and survival. Ann Surg 1987;206:115-125.
40. Wilkin JK, Rowntree CB. Blockade of carcinoid flush with cimetidine and cloridine. Arch Dermatol 1982;118:109-111.
41. Camisa C. Somatostatin and a long acting analogue, octreotide acetate. Arch Dermatol 1989;125:407-412.
42. Maton PN, Camilleri M, Griffin G et al. Role of hepatic arterial embolisation in the carcinoid syndrome. Br Med J 1983;287:932-935.
43. Marsh HM. Carcinoid crisis during anaesthetic: successful treatment with a somatostatin analogue. Anaesthesiology 1987;66:89-91.
44. Oberg K, Norheim I, Lind E. Treatment of malignant carcinoid tumours with human leukocyte interferon. Long term results. Cancer Treat Rep 1986;70:1297-1304.
45. Schwartz LB, Irani AA, Roller K et al. Quantitation of histamine tryptase and chymase in dispersed human T and TC mast cells. J Immunol 1987;138:2611-2615.
46. Walsh LJ, Trinchieri G, Waldorf HA et al. Human dermal mast cells contain and release tumour necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991;88:4220-4224.
47. 2 overproduction in systemic mastocytosis. N Engl J Med 1982;307:186.
48. Mallet AI, Norris P, Rendell NB, Greaves MW. The effect of disodium cromoglycate and ketotifen on the excretion of histamine and N-methyl imidazole acetic acid in the urine of patients with mastocytosis. Br J Clin Pharmacol 1989;27: 88-91.
49. Schwartz LB, Atkins PC, Bradford TR et al. Release of tryptase together with histamine during the immediate cutaneous response to allergen. J Allergy Clin Immunol 1987;80:850-855.
50. Robertson I, Greaves MW. Responses of human skin blood vessels to synthetic histamine analogues. Br J Clin Pharmacol 1978;5:319-322.
51. 2 receptor blocking agent. Br J Clin Pharmacol 1977;4:367-369.
52. Soter NA, Austen KF, Wasserman SI. Oral disodium cromoglycote in the treatment of systemic mastocytosis. N Engl J Med 1979;301:465-469.
53. Kolde G, Sunderkotter C, Luger TA. Treatment of urticaria pigmentosa using interferon alpha. Br J Dermatol 1995;133:91-94.
54. Czametzki BM, Algermissen B, Jeep S et al. Interferon treatment of patients with chronic urticaria and mastocytosis. J Am Acad Dermatol 1994;30:500-501.
55. Fiehn C, Prummer O, Gallati H et al. Treatment of systemic mastocytosis with interferon gamma: failure of the appearance of anti-IFN-gamma antibodies. Eur J Clin Invest 1995;25:615-618.
56. Bernstein JG, Soltani K. Alcohol-induced rosacea blocked by naloxone. Br J Dermatol 1982;107:59-62.
57. Anon. Rosacea in hot water. Lancet 1981;1:647.
58. Starr PAJ. Oculocutaneous aspects of rosacea. Proc R Soc Med 1969;62:9-11.
59. Marks R. Concepts in the pathogenesis of rosacea. Br J Dermatol 1968;80:170-177.
60. Wilkin JK. Effect of nadolol on flushing reactions in rosacea. J Am Acad Dermatol 1989;20:202-205.